Prognostic value of U2AF1 mutant in patients with de novo myelodysplastic syndromes: a meta-analysis Huifang WangNanchen ZhangYuping Gong Review Article 21 November 2019 Pages: 2629 - 2639
New insights inside the interdigitating dendritic cell sarcoma—pooled analysis and review of literature Amr MuhammedAhmed R. H. AhmedEsraa Elnakib Review Article 18 November 2019 Pages: 2641 - 2651
Non-invasive urinary biomarkers of renal function in sickle cell disease: an overview Marília Rocha LaurentinoSérgio Luiz Arruda Parente FilhoRomélia Pinheiro Gonçalves Lemes Review Article 23 October 2019 Pages: 2653 - 2660
CRISPR/Cas9 gene correction of HbH-CS thalassemia-induced pluripotent stem cells Xie YingjunXie YuhuanSun Xiaofang Original Article Open access 09 September 2019 Pages: 2661 - 2671
Genetic modulators of fetal hemoglobin expression and ischemic stroke occurrence in African descendant children with sickle cell anemia Marta NicolauSofia VargasPaula Faustino Original Article 02 September 2019 Pages: 2673 - 2681
Acute porphyrias: a German monocentric study of the biochemical, molecular genetic, and clinical data of 62 families Olivia BronischThomas StauchPetro E. Petrides Original Article 19 November 2019 Pages: 2683 - 2691
Magnetic resonance imaging reveals distinct bone marrow patterns in indolent and advanced systemic mastocytosis Philipp RiffelMohamad JawharAndreas Reiter Original Article 05 November 2019 Pages: 2693 - 2701
Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasms Martin KirschnerAnne BornemannSteffen Koschmieder Original Article 20 November 2019 Pages: 2703 - 2709
Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission—a multi-center historical control study Tamar BergerUri RozovskiOfir Wolach Original Article 11 September 2019 Pages: 2711 - 2717
Residual methylation of tumor suppressor gene promoters, RASSF6 and RASSF10, as novel biomarkers for minimal residual disease detection in adult acute lymphoblastic leukemia Samareh YounesianSepideh ShahkaramiSeyed H. Ghaffari Original Article 05 September 2019 Pages: 2719 - 2727
Is bendamustine-rituximab a reasonable treatment in selected older patients with diffuse large B cell lymphoma? Results from a multicentre, retrospective study Vanja ZeremskiKathleen Jentsch-UllrichEnrico Schalk Original Article 08 November 2019 Pages: 2729 - 2737
Early risk stratification for diffuse large B-cell lymphoma integrating interim Deauville score and International Prognostic Index Sung Kyun YimHo-Young YhimJae-Yong Kwak Original Article 11 November 2019 Pages: 2739 - 2748
Single-agent ibrutinib in RESONATE-2™ and RESONATE™ versus treatments in the real-world PHEDRA databases for patients with chronic lymphocytic leukemia Gilles SallesEmmanuel BachyMichael Doubek Original Article Open access 19 November 2019 Pages: 2749 - 2760
Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort Study Börge SchmidtElisabeth DeboldLewin Eisele Original Article 06 November 2019 Pages: 2761 - 2767
Enrichment of circulating myeloma cells by immunomagnetic beads combined with flow cytometry for monitoring minimal residual disease and relapse in patients with multiple myeloma Ningning WangNahom TesfaluulBaohong Yue Original Article 20 November 2019 Pages: 2769 - 2780
RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group Sini LuomaPekka AnttilaRaija Silvennoinen Original Article Open access 31 October 2019 Pages: 2781 - 2792
Peripheral neuropathy following bortezomib therapy in multiple myeloma patients: association with cumulative dose, heparanase, and TNF-α Weiwei ZhaoWei WangYing Wang Original Article 25 October 2019 Pages: 2793 - 2803
Daratumumab plus bortezomib, melphalan, and prednisone in East Asian patients with non-transplant multiple myeloma: subanalysis of the randomized phase 3 ALCYONE trial Tomoaki FujisakiTakayuki IshikawaKoji Nagafuji Original Article Open access 16 October 2019 Pages: 2805 - 2814
Outcomes of allogeneic stem cell transplantation for DLBCL: a multi-center study from the Kyoto Stem Cell Transplantation Group Kiyotaka IzumiJunya KandaAkifumi Takaori-Kondo Original Article 12 November 2019 Pages: 2815 - 2823
Aggressive systemic mastocytosis: a diagnostic challenge in a patient with myotonic dystrophy type 2: a case report Christin Le Hoa TranNadja JaekelHaifa Kathrin Al-Ali Letter to the Editor 09 November 2019 Pages: 2825 - 2827
A new SH2D1A mutation in a female adult XLP disease with hemophagocytic lymphohistiocytosis and NK-cell leukemia Jin-Hua LiangHua-Yuan ZhuWei Xu Letter to the Editor 22 November 2019 Pages: 2829 - 2831
Secondary haploidentical hematopoietic stem cell transplantation in patients with relapse or graft failure after initial hematopoietic stem cell transplantation Chang HouNan ChenDepei Wu Letter to the Editor 18 November 2019 Pages: 2833 - 2836
Double hit B cell precursor leukemia/lymphoma in a patient with a prior diagnosis of follicular lymphoma: a diagnostic and therapeutic dilemma Carlos Bravo-PerezInmaculada PajaresFrancisco Jose Ortuño Letter to the Editor 11 November 2019 Pages: 2837 - 2839
Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement developing after low-dose methotrexate therapy for rheumatoid arthritis Kazuhisa ChonabayashiYoshinori YoshidaAkifumi Takaori-Kondo Letter to the Editor 14 November 2019 Pages: 2841 - 2843
Response to interferon treatment in essential thrombocythemia with inv(3)(q21q26) Radhika GangarajuAndrew J. CarrollJosef T. Prchal Letter to the Editor 01 November 2019 Pages: 2845 - 2846
Atypical primary cutaneous cryptococcosis during ibrutinib therapy for chronic lymphocytic leukemia Anna Maria PeriRaffaella RossioFlora Peyvandi Letter to the Editor 18 November 2019 Pages: 2847 - 2849
Unexpected response of extramedullary plasmacytoma in patients with lung cancer who received nivolumab Ou YamaguchiK. KairaH. Kagamu Letter to the Editor 16 November 2019 Pages: 2851 - 2852
Hemoglobin Kirklareli [Α2 59(E7) His>Leu; HBA2:c.176A>T] in a Brazilian child with severe dyspnea and low O2 saturation G. A. PedrosoP. FernandesM. F. Sonati Letter to the Editor 11 November 2019 Pages: 2853 - 2855
Correction to: prediction of thrombosis risk in patients with paroxysmal nocturnal hemoglobinuria Yuzhou HuangXinjian LiuBing Han Correction 15 November 2019 Pages: 2857 - 2857